Literature DB >> 10777782

Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons.

A C Granholm1, M Reyland, D Albeck, L Sanders, G Gerhardt, G Hoernig, L Shen, H Westphal, B Hoffer.   

Abstract

Glial cell line-derived neurotrophic factor (GDNF) is one of the most potent trophic factors that have been identified for midbrain dopamine (DA) neurons. Null mutations for trophic factor genes have been used frequently for studies of the role of these important proteins in brain development. One problem with these studies has been that often only prenatal development can be studied because many of the knockout strains, such as those with GDNF null mutations, will die shortly after birth. In this study, we looked at the continued fate of specific neuronal phenotypes from trophic factor knockout mice beyond the time that these animals die. By transplanting fetal neural tissues from GDNF -/-, GDNF +/-, and wild-type (WT) mice into the brain of adult wild-type mice, we demonstrate that the continued postnatal development of ventral midbrain dopamine neurons is severely disturbed as a result of the GDNF null mutation. Ventral midbrain grafts from -/- fetuses have markedly reduced DA neuron numbers and fiber outgrowth. Moreover, DA neurons in such transplants can be "rescued" by immersion in GDNF before grafting. These findings suggest that postnatal survival and/or phenotypic expression of ventral mesencephalic DA neurons is dependent on GDNF. In addition, we present here a strategy for studies of maturation and even aging of tissues from trophic factor and other knockout animals that do not survive past birth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777782      PMCID: PMC6773139     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

1.  Characterization of a multicomponent receptor for GDNF.

Authors:  J J Treanor; L Goodman; F de Sauvage; D M Stone; K T Poulsen; C D Beck; C Gray; M P Armanini; R A Pollock; F Hefti; H S Phillips; A Goddard; M W Moore; A Buj-Bello; A M Davies; N Asai; M Takahashi; R Vandlen; C E Henderson; A Rosenthal
Journal:  Nature       Date:  1996-07-04       Impact factor: 49.962

2.  Renal and neuronal abnormalities in mice lacking GDNF.

Authors:  M W Moore; R D Klein; I Fariñas; H Sauer; M Armanini; H Phillips; L F Reichardt; A M Ryan; K Carver-Moore; A Rosenthal
Journal:  Nature       Date:  1996-07-04       Impact factor: 49.962

3.  The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra.

Authors:  T F Oo; R E Burke
Journal:  Brain Res Dev Brain Res       Date:  1997-02-20

4.  Human ventral mesencephalic xenografts to the catecholamine-depleted striata of athymic rats: ultrastructure and immunocytochemistry.

Authors:  T J Mahalik; I Strömberg; G A Gerhardt; A C Granholm; A Seiger; M Bygdeman; L Olson; B J Hoffer; T E Finger
Journal:  Synapse       Date:  1989       Impact factor: 2.562

5.  Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum.

Authors:  A C Granholm; J L Mott; K Bowenkamp; S Eken; S Henry; B J Hoffer; P A Lapchak; M R Palmer; C van Horne; G A Gerhardt
Journal:  Exp Brain Res       Date:  1997-08       Impact factor: 1.972

6.  Need for caspases in apoptosis of trophic factor-deprived PC12 cells.

Authors:  R Haviv; L Lindenboim; H Li; J Yuan; R Stein
Journal:  J Neurosci Res       Date:  1997-10-01       Impact factor: 4.164

7.  GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF.

Authors:  S Jing; D Wen; Y Yu; P L Holst; Y Luo; M Fang; R Tamir; L Antonio; Z Hu; R Cupples; J C Louis; S Hu; B W Altrock; G M Fox
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

8.  Morphological alterations in the peripheral and central nervous systems of mice lacking glial cell line-derived neurotrophic factor (GDNF): immunohistochemical studies.

Authors:  A C Granholm; N Srivastava; J L Mott; S Henry; M Henry; H Westphal; J G Pichel; L Shen; B J Hoffer
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

9.  Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms.

Authors:  M D Lindner; S R Winn; E E Baetge; J P Hammang; F T Gentile; E Doherty; P E McDermott; B Frydel; M D Ullman; T Schallert
Journal:  Exp Neurol       Date:  1995-03       Impact factor: 5.330

10.  Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo.

Authors:  M Johansson; M Friedemann; B Hoffer; I Strömberg
Journal:  Exp Neurol       Date:  1995-07       Impact factor: 5.330

View more
  43 in total

1.  Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a.

Authors:  Gonçalo Castelo-Branco; Joseph Wagner; Francisco J Rodriguez; Julianna Kele; Kyle Sousa; Nina Rawal; Hilda Amalia Pasolli; Elaine Fuchs; Jan Kitajewski; Ernest Arenas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

2.  Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system.

Authors:  Jun Wang; Sebastien Carnicella; Somayeh Ahmadiantehrani; Dao-Yao He; Segev Barak; Viktor Kharazia; Sami Ben Hamida; Agustin Zapata; Toni S Shippenberg; Dorit Ron
Journal:  J Neurosci       Date:  2010-10-27       Impact factor: 6.167

Review 3.  Glial-derived neurotrophic factor gene transfer for Parkinson's disease: anterograde distribution of AAV2 vectors in the primate brain.

Authors:  Adrian P Kells; John Forsayeth; Krystof S Bankiewicz
Journal:  Neurobiol Dis       Date:  2011-10-14       Impact factor: 5.996

4.  An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).

Authors:  Russell W Brown; Seth L Kirby; Adam R Denton; John M Dose; Elizabeth D Cummins; Wesley Drew Gill; Katherine C Burgess
Journal:  Schizophr Res       Date:  2017-03-14       Impact factor: 4.939

5.  Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF.

Authors:  Ofelia M Littrell; Ann-Charlotte Granholm; Greg A Gerhardt; Heather A Boger
Journal:  Pharmacol Biochem Behav       Date:  2013-01-02       Impact factor: 3.533

6.  Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity.

Authors:  Brandon S Pruett; Michael F Salvatore
Journal:  Mol Neurobiol       Date:  2013-01-16       Impact factor: 5.590

Review 7.  Neurotrophic factors for the investigation and treatment of movement disorders.

Authors:  Justo Garcia De Yébenes; Marina Sánchez; Maria Angeles Mena
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

8.  Altered serum levels of glial cell line-derived neurotrophic factor in male chronic schizophrenia patients with tardive dyskinesia.

Authors:  Fei Ye; Qiongqiong Zhan; Wenhuan Xiao; Weiwei Sha; Xiaobin Zhang
Journal:  Int J Methods Psychiatr Res       Date:  2018-06-14       Impact factor: 4.035

Review 9.  Neurotrophic Factors and Their Potential Applications in Tissue Regeneration.

Authors:  Nan Xiao; Quynh-Thu Le
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-11-26       Impact factor: 4.291

10.  Excessive alcohol consumption is blocked by glial cell line-derived neurotrophic factor.

Authors:  Sebastien Carnicella; Ryoji Amamoto; Dorit Ron
Journal:  Alcohol       Date:  2009-02       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.